REPORT ID 1554

EMEA (Europe, Middle East and Africa) Circulating Tumor Cells Market Report 2019

Publish Date
2019
Pages
111
Format
Electronic (PDF)

In this report, the EMEA Circulating Tumor Cells market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Circulating Tumor Cells for these regions, from   2019 to 2025 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Circulating Tumor Cells market competition by top manufacturers/players, with Circulating Tumor Cells sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Janssen
    Qiagen?Adnagen?
    Acousys Biodevices
    ApoCell
    Advanced Cell Diagnostics
    Fluxion Biosciences
    Biocept
    Fluidigm
    Epic Sciences
    Clearbridge Biomedics
    Cynvenio
    CytoTrack
    ScreenCell
    Creatv Microtech
    Aviva Biosciences
    Greiner Bio-one
    Sysmex
    Ikonisys

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    CTC Enrichment
    CTC Detection
    CTC Analysis

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Prostate Cancer
    Breast Cancer
    Colorectal Cancer
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Circulating Tumor Cells Market  Report 2019
1 Circulating Tumor Cells Overview
    1.1 Product Overview and Scope of Circulating Tumor Cells
    1.2 Classification of Circulating Tumor Cells
        1.2.1 EMEA Circulating Tumor Cells Market Size (Sales) Comparison by Type ( 2014-2024)
        1.2.2 EMEA Circulating Tumor Cells Market Size (Sales) Market Share by Type (Product Category)  in 2018
        1.2.3 CTC Enrichment
        1.2.4 CTC Detection
        1.2.5 CTC Analysis
    1.3 EMEA Circulating Tumor Cells Market by Application/End Users
        1.3.1 EMEA Circulating Tumor Cells Sales (Volume) and Market Share Comparison by Application ( 2014-2024
        1.3.2 Prostate Cancer
        1.3.3 Breast Cancer
        1.3.4 Colorectal Cancer
        1.3.5 Others
    1.4 EMEA Circulating Tumor Cells Market by Region
        1.4.1 EMEA Circulating Tumor Cells Market Size (Value) Comparison by Region ( 2014-2024)
        1.4.2 Europe Status and Prospect ( 2014-2024)
        1.4.3 Middle East Status and Prospect ( 2014-2024)
        1.4.4 Africa Status and Prospect ( 2014-2024)
    1.5 EMEA Market Size (Value and Volume) of Circulating Tumor Cells ( 2014-2024)
        1.5.1 EMEA Circulating Tumor Cells Sales and Growth Rate ( 2014-2024)
        1.5.2 EMEA Circulating Tumor Cells Revenue and Growth Rate ( 2014-2024)

2 EMEA Circulating Tumor Cells Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Circulating Tumor Cells Market Competition by Players/Manufacturers
        2.1.1 EMEA Circulating Tumor Cells Sales Volume and Market Share of Major Players ( 2014-2019)
        2.1.2 EMEA Circulating Tumor Cells Revenue and Share by Players ( 2014-2019)
        2.1.3 EMEA Circulating Tumor Cells Sale Price by Players ( 2014-2019)
    2.2 EMEA Circulating Tumor Cells (Volume and Value) by Type/Product Category
        2.2.1 EMEA Circulating Tumor Cells Sales and Market Share by Type ( 2014-2019)
        2.2.2 EMEA Circulating Tumor Cells Revenue and Market Share by Type ( 2014-2019)
        2.2.3 EMEA Circulating Tumor Cells Sale Price by Type ( 2014-2019)
    2.3 EMEA Circulating Tumor Cells (Volume) by Application
    2.4 EMEA Circulating Tumor Cells (Volume and Value) by Region
        2.4.1 EMEA Circulating Tumor Cells Sales and Market Share by Region ( 2014-2019)
        2.4.2 EMEA Circulating Tumor Cells Revenue and Market Share by Region ( 2014-2019)
        2.4.3 EMEA Circulating Tumor Cells Sales Price by Region ( 2014-2019)

3 Europe Circulating Tumor Cells (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Circulating Tumor Cells Sales and Value ( 2014-2019)
        3.1.1 Europe Circulating Tumor Cells Sales Volume and Growth Rate ( 2014-2019)
        3.1.2 Europe Circulating Tumor Cells Revenue and Growth Rate ( 2014-2019)
    3.2 Europe Circulating Tumor Cells Sales and Market Share by Type
    3.3 Europe Circulating Tumor Cells Sales and Market Share by Application
    3.4 Europe Circulating Tumor Cells Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Circulating Tumor Cells Sales Volume by Countries ( 2014-2019)
        3.4.2 Europe Circulating Tumor Cells Revenue by Countries ( 2014-2019)
        3.4.3 Germany Circulating Tumor Cells Sales and Growth Rate ( 2014-2019)
        3.4.4 France Circulating Tumor Cells Sales and Growth Rate ( 2014-2019)
        3.4.5 UK Circulating Tumor Cells Sales and Growth Rate ( 2014-2019)
        3.4.6 Russia Circulating Tumor Cells Sales and Growth Rate ( 2014-2019)
        3.4.7 Italy Circulating Tumor Cells Sales and Growth Rate ( 2014-2019)
        3.4.8 Benelux Circulating Tumor Cells Sales and Growth Rate ( 2014-2019)

4 Middle East Circulating Tumor Cells (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Circulating Tumor Cells Sales and Value ( 2014-2019)
        4.1.1 Middle East Circulating Tumor Cells Sales Volume and Growth Rate ( 2014-2019)
        4.1.2 Middle East Circulating Tumor Cells Revenue and Growth Rate ( 2014-2019)
    4.2 Middle East Circulating Tumor Cells Sales and Market Share by Type
    4.3 Middle East Circulating Tumor Cells Sales and Market Share by Application
    4.4 Middle East Circulating Tumor Cells Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Circulating Tumor Cells Sales Volume by Countries ( 2014-2019)
        4.4.2 Middle East Circulating Tumor Cells Revenue by Countries ( 2014-2019)
        4.4.3 Saudi Arabia Circulating Tumor Cells Sales and Growth Rate ( 2014-2019)
        4.4.4 Israel Circulating Tumor Cells Sales and Growth Rate ( 2014-2019)
        4.4.5 UAE Circulating Tumor Cells Sales and Growth Rate ( 2014-2019)
        4.4.6 Iran Circulating Tumor Cells Sales and Growth Rate ( 2014-2019)

5 Africa Circulating Tumor Cells (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Circulating Tumor Cells Sales and Value ( 2014-2019)
        5.1.1 Africa Circulating Tumor Cells Sales Volume and Growth Rate ( 2014-2019)
        5.1.2 Africa Circulating Tumor Cells Revenue and Growth Rate ( 2014-2019)
    5.2 Africa Circulating Tumor Cells Sales and Market Share by Type
    5.3 Africa Circulating Tumor Cells Sales and Market Share by Application
    5.4 Africa Circulating Tumor Cells Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Circulating Tumor Cells Sales Volume by Countries ( 2014-2019)
        5.4.2 Africa Circulating Tumor Cells Revenue by Countries ( 2014-2019)
        5.4.3 South Africa Circulating Tumor Cells Sales and Growth Rate ( 2014-2019)
        5.4.4 Nigeria Circulating Tumor Cells Sales and Growth Rate ( 2014-2019)
        5.4.5 Egypt Circulating Tumor Cells Sales and Growth Rate ( 2014-2019)
        5.4.6 Algeria Circulating Tumor Cells Sales and Growth Rate ( 2014-2019)

6 EMEA Circulating Tumor Cells Manufacturers/Players Profiles and Sales Data
    6.1 Janssen
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Circulating Tumor Cells Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Janssen Circulating Tumor Cells Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.1.4 Main Business/Business Overview
    6.2 Qiagen?Adnagen?
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Circulating Tumor Cells Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Qiagen?Adnagen? Circulating Tumor Cells Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.2.4 Main Business/Business Overview
    6.3 Acousys Biodevices
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Circulating Tumor Cells Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Acousys Biodevices Circulating Tumor Cells Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.3.4 Main Business/Business Overview
    6.4 ApoCell
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Circulating Tumor Cells Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 ApoCell Circulating Tumor Cells Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.4.4 Main Business/Business Overview
    6.5 Advanced Cell Diagnostics
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Circulating Tumor Cells Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Advanced Cell Diagnostics Circulating Tumor Cells Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.5.4 Main Business/Business Overview
    6.6 Fluxion Biosciences
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Circulating Tumor Cells Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Fluxion Biosciences Circulating Tumor Cells Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.6.4 Main Business/Business Overview
    6.7 Biocept
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Circulating Tumor Cells Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Biocept Circulating Tumor Cells Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.7.4 Main Business/Business Overview
    6.8 Fluidigm
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Circulating Tumor Cells Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Fluidigm Circulating Tumor Cells Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.8.4 Main Business/Business Overview
    6.9 Epic Sciences
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Circulating Tumor Cells Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Epic Sciences Circulating Tumor Cells Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.9.4 Main Business/Business Overview
    6.10 Clearbridge Biomedics
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Circulating Tumor Cells Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Clearbridge Biomedics Circulating Tumor Cells Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.10.4 Main Business/Business Overview
    6.11 Cynvenio
    6.12 CytoTrack
    6.13 ScreenCell
    6.14 Creatv Microtech
    6.15 Aviva Biosciences
    6.16 Greiner Bio-one
    6.17 Sysmex
    6.18 Ikonisys

7 Circulating Tumor Cells Manufacturing Cost Analysis
    7.1 Circulating Tumor Cells Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Circulating Tumor Cells

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Circulating Tumor Cells Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Circulating Tumor Cells Major Manufacturers  in 2018
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Circulating Tumor Cells Market Forecast ( 2019-2025)
    11.1 EMEA Circulating Tumor Cells Sales, Revenue and Price Forecast ( 2019-2025)
        11.1.1 EMEA Circulating Tumor Cells Sales and Growth Rate Forecast ( 2019-2025)
        11.1.2 EMEA Circulating Tumor Cells Revenue and Growth Rate Forecast ( 2019-2025)
        11.1.3 EMEA Circulating Tumor Cells Price and Trend Forecast ( 2019-2025)
    11.2 EMEA Circulating Tumor Cells Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.3 Europe Circulating Tumor Cells Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.4 Middle Eastt Circulating Tumor Cells Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.5 Africa Circulating Tumor Cells Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.6 EMEA Circulating Tumor Cells Sales Forecast by Type ( 2019-2025)
    11.7 EMEA Circulating Tumor Cells Sales Forecast by Application ( 2019-2025)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer